FIELD: medicine, obstetrics.
SUBSTANCE: group of inventions relates to prevention of hemoreological disorders in pregnant women with obliterate forms of hyperandrogenia (HA). For this purpose claimed is medicaton Sulodexide. Medication is administered in dose 600LU i/m 1 time a day during 10 days. After that, peroral introduction is administered in dose 250LU 2 times a day for period not shorter than one month.
EFFECT: method ensures normalisation of uterine-placental blood flow at the background of sclerotic changes in microcirculatory stream, increased fragility of miometrium and placenta vessels, induced by androgen excess in patients of said group, in structural and chronometric isocoagulation.
2 cl, 4 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF FETOPLACENTAL INSUFFICIENCY IN GESTATIONAL AUTOHEMODILUTION | 2008 |
|
RU2375087C1 |
| METHOD OF PREDICTING PLACENTAL INSUFFICIENCY IN PREGNANT WOMEN WITH MIXED FORMS OF HYPERANDROGENY | 2010 |
|
RU2436513C1 |
| METHOD AND AGENT FOR TREATMENT OF DEPRESSION DURING PREGNANCY AT WOMEN WITH SYNDROME OF LOSS OF FETUS IN ANAMNESIS | 2007 |
|
RU2350328C1 |
| METHOD FOR PREVENTING PATHOLOGICAL PREGNANCY SYNDROME | 2015 |
|
RU2575789C1 |
| METHOD FOR PROPHYLAXIS OF CHRONIC PYELONEPHRITIS EXACERBATION IN PREGNANT FEMALES | 2005 |
|
RU2299728C1 |
| COMPOSITION AND METHOD FOR TREATMENT OF FETOPLACENTAL INSUFFICIENCY | 2006 |
|
RU2324486C2 |
| METHOD FOR PREVENTING CHRONIC HYPOXIA AND FOETAL DEVELOPMENT RETARDATION | 2018 |
|
RU2699559C2 |
| PHARMACEUTICAL COMPOSITION BASED ON SUBSTANCES INFLUENCING ON ENERGETIC METABOLISM AND METHOD FOR PROPHYLAXIS OF FETOPLACENTAL INSUFFICIENCY IN PREGNANT OF HIGH RISK GROUP | 2003 |
|
RU2282439C2 |
| METHOD OF PREVENTING SEVERE FORMS OF OBSTETRICAL PATHOLOGY | 2010 |
|
RU2422149C1 |
| MEDICATIONS FOR COMPLEX TREATMENT OF IRON-DEFICIENCY ANEMIA IN PREGNANT WOMEN AND METHOD OF TREATMENT | 2009 |
|
RU2419425C2 |
